trial
as of 2026-07-01Using Transcranial Magnetic Stimulation (TMS) to Understand Hallucinations in Schizophrenia
NCTId NCT05343598
at a glance
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Recruiting
Enrollment
68 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Quadruple
Start
2021-10-13
Primary completion
2026-10-31
Eligibility
ALL · 18 Years · 55 Years
Interventions & indications
Sponsors
Mclean HospitalLead Sponsor
Beth Israel Deaconess Medical CenterCollaborator
National Institute of Mental Health (NIMH)Collaborator
Investigators
1
Mark Halko, PhDPrincipal Investigator
Sites
1 total
Belmont, United States
Facts & assertions
4 sourced
Enrollment
68
Phase
NA
Primary Completion Date
2026-10-31
Status
RECRUITING
relationships
The graph out of here
lead_sponsor
company
collaborator
indication
investigator
person